Ativa Medical, developer of the world’s first diagnostic micro lab to help clinicians make immediate treatment decisions, today announced that longtime biotechnology industry executive Mark N.K. Bagnall has joined its board of directors.
Bagnall, currently COO of Naia Pharmaceuticals, has served as CEO, CFO and audit committee chair of several public and private biotech companies in his 25-year career. As president and CEO of GenturaDx, a Chinese/American molecular diagnostics company, he successfully managed the turnaround and sale of the company to Luminex in 2012.
Help employers find you! Check out all the jobs and post your resume.
